Thelin Eric Peter, Nelson David W, Vehviläinen Juho, Nyström Harriet, Kivisaari Riku, Siironen Jari, Svensson Mikael, Skrifvars Markus B, Bellander Bo-Michael, Raj Rahul
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.
PLoS Med. 2017 Aug 3;14(8):e1002368. doi: 10.1371/journal.pmed.1002368. eCollection 2017 Aug.
Traumatic brain injury (TBI) is a major contributor to morbidity and mortality. Computerized tomography (CT) scanning of the brain is essential for diagnostic screening of intracranial injuries in need of neurosurgical intervention, but may also provide information concerning patient prognosis and enable baseline risk stratification in clinical trials. Novel CT scoring systems have been developed to improve current prognostic models, including the Stockholm and Helsinki CT scores, but so far have not been extensively validated. The primary aim of this study was to evaluate the Stockholm and Helsinki CT scores for predicting functional outcome, in comparison with the Rotterdam CT score and Marshall CT classification. The secondary aims were to assess which individual components of the CT scores best predict outcome and what additional prognostic value the CT scoring systems contribute to a clinical prognostic model.
TBI patients requiring neuro-intensive care and not included in the initial creation of the Stockholm and Helsinki CT scoring systems were retrospectively included from prospectively collected data at the Karolinska University Hospital (n = 720 from 1 January 2005 to 31 December 2014) and Helsinki University Hospital (n = 395 from 1 January 2013 to 31 December 2014), totaling 1,115 patients. The Marshall CT classification and the Rotterdam, Stockholm, and Helsinki CT scores were assessed using the admission CT scans. Known outcome predictors at admission were acquired (age, pupil responsiveness, admission Glasgow Coma Scale, glucose level, and hemoglobin level) and used in univariate, and multivariable, regression models to predict long-term functional outcome (dichotomizations of the Glasgow Outcome Scale [GOS]). In total, 478 patients (43%) had an unfavorable outcome (GOS 1-3). In the combined cohort, overall prognostic performance was more accurate for the Stockholm CT score (Nagelkerke's pseudo-R2 range 0.24-0.28) and the Helsinki CT score (0.18-0.22) than for the Rotterdam CT score (0.13-0.15) and Marshall CT classification (0.03-0.05). Moreover, the Stockholm and Helsinki CT scores added the most independent prognostic value in the presence of other known clinical outcome predictors in TBI (6% and 4%, respectively). The aggregate traumatic subarachnoid hemorrhage (tSAH) component of the Stockholm CT score was the strongest predictor of unfavorable outcome. The main limitations were the retrospective nature of the study, missing patient information, and the varying follow-up time between the centers.
The Stockholm and Helsinki CT scores provide more information on the damage sustained, and give a more accurate outcome prediction, than earlier classification systems. The strong independent predictive value of tSAH may reflect an underrated component of TBI pathophysiology. A change to these newer CT scoring systems may be warranted.
创伤性脑损伤(TBI)是导致发病和死亡的主要原因。脑部计算机断层扫描(CT)对于需要神经外科干预的颅内损伤的诊断筛查至关重要,但也可提供有关患者预后的信息,并有助于在临床试验中进行基线风险分层。已开发出新型CT评分系统以改进当前的预后模型,包括斯德哥尔摩CT评分和赫尔辛基CT评分,但迄今为止尚未得到广泛验证。本研究的主要目的是评估斯德哥尔摩CT评分和赫尔辛基CT评分对功能结局的预测能力,并与鹿特丹CT评分和马歇尔CT分级进行比较。次要目的是评估CT评分的哪些个体成分最能预测结局,以及CT评分系统对临床预后模型有何额外的预后价值。
从卡罗林斯卡大学医院(2005年1月1日至2014年12月31日,共720例)和赫尔辛基大学医院(2013年1月1日至2014年12月31日,共395例)前瞻性收集的数据中,回顾性纳入需要神经重症监护且未纳入斯德哥尔摩和赫尔辛基CT评分系统初始创建的TBI患者,共计1115例。使用入院时的CT扫描评估马歇尔CT分级以及鹿特丹、斯德哥尔摩和赫尔辛基CT评分。获取入院时已知的结局预测因素(年龄、瞳孔反应性、入院时格拉斯哥昏迷量表、血糖水平和血红蛋白水平),并将其用于单变量和多变量回归模型,以预测长期功能结局(格拉斯哥结局量表[GOS]的二分法)。共有478例患者(43%)预后不良(GOS 1 - 3)。在合并队列中,斯德哥尔摩CT评分(Nagelkerke伪R²范围为0.24 - 0.28)和赫尔辛基CT评分(0.18 - 0.22)的总体预后表现比鹿特丹CT评分(0.13 - 0.15)和马歇尔CT分级(0.03 - 0.05)更准确。此外,在存在其他已知的TBI临床结局预测因素时,斯德哥尔摩和赫尔辛基CT评分增加的独立预后价值最大(分别为6%和4%)。斯德哥尔摩CT评分中的创伤性蛛网膜下腔出血(tSAH)总成分是预后不良的最强预测因素。主要局限性在于研究的回顾性性质、患者信息缺失以及各中心随访时间不同。
与早期分类系统相比,斯德哥尔摩和赫尔辛基CT评分能提供更多关于所受损伤的信息,并给出更准确的结局预测。tSAH的强大独立预测价值可能反映了TBI病理生理学中一个被低估的成分。可能有必要改用这些更新的CT评分系统。